跳至主要内容
临床试验/NCT04500002
NCT04500002Unknown不适用

Adjuvant Isonicotinic Acid Hydrazide (INH) Pretreatment With Misoprostol for Induction of Abortion in First-trimester Missed Miscarriage: A Randomized Controlled Trial

Aswan University Hospital1 个研究点 分布在 1 个国家目标入组 240 人开始时间: 2020年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
240
试验地点
1
主要终点
number of patients with complete abortion

研究概览

简要总结

The primary endpoint was the success rate of adjuvant isonicotinic acid hydrazide (INH) and misoprostol versus misoprostol alone for medical termination of first-trimester pregnancy.

详细描述

According to the American college of obstetricians and gynecologists (2005), medical abortion is an acceptable alternative for surgical procedures in pregnant women with gestational age of less than 10 weeks based on the last menstrual period

Oral or vaginal misoprostol causes complete abortion in almost 85% of cases within seven days before the 12th week

Adjuvant isonicotinic acid hydrazide (INH) administration with misoprostol raises the rate of complete abortion

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

double blind randomized parallel assign controlled trial

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Gestational age less than 70 days gestation (<10 wks)
  • Hemoglobin >10 g/dL.
  • BMI between 18.5 kg/m2 and 30 kg/m
  • Missed abortion

排除标准

  • Molar pregnancy.
  • Fibroid uterus.
  • Uterine anomalies.
  • Coagulopathy.
  • Medical disorder that contraindicate induction of abortion (e.g. heart failure).
  • Previous attempts for induction of abortion in the current pregnancy.
  • Allergy to misoprostol or letrozole.
  • Scared uterus (previous myomectomy, cesarean section, hysterectomy and ruptured uterus).

研究组 & 干预措施

INH

Experimental

3 tablets of isonicotinic acid hydrazide 300 mg will be given as single daily doses, 5 mg per day for two days at home and the third dose will be given on admission to hospital on day 3 and will be followed by vaginal misoprostol 800 mcg every three hours up to maximum three doses.

干预措施: Isonicotinic Acid Hydrazide (Drug)

INH

Experimental

3 tablets of isonicotinic acid hydrazide 300 mg will be given as single daily doses, 5 mg per day for two days at home and the third dose will be given on admission to hospital on day 3 and will be followed by vaginal misoprostol 800 mcg every three hours up to maximum three doses.

干预措施: Misoprostol (Drug)

Misoprostol

Active Comparator

Misoprostol Alone 800 mcg every three hours up to maximum three doses

干预措施: Misoprostol (Drug)

结局指标

主要结局

number of patients with complete abortion

时间窗: 12 hours

number of patients with complete abortion

time from induction to abortion

时间窗: 12 hours

time from induction to abortion

次要结局

  • number of the women will undergo dilatation and curettage after failed medical induction of abortion(12 hours)

研究者

发起方
Aswan University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

hany farouk

A Professor

Aswan University Hospital

研究点 (1)

Loading locations...

相似试验